To address this question, the effect of progestin dose on breast cancer cell invasiveness was tested in the absence or presence of 1nM E2 using recombinant T47D cells that exclusively express PR-A (T47D-A cells) or PR-B (T47D-B cells) (Figure 3A). Here, RB1 is linked to breast carcinoma.